
    
      A Multi-center, Randomized, Double-Blind, Active-controlled, Phase 3, Therapeutic
      Confirmatory Study to Evaluate the Efficacy and Safety of DWP16001 in Combination with
      Metformin in Patients With Type 2 Diabetes Mellitus who Have Inadequate Glycemic Control on
      Metformin Alone.
    
  